@kavi_deniz: We’re proud to share that @TamarindBio has been selected to build, host, and operate the inference infrastructure layer…
Summary
TamarindBio has been selected to build, host, and operate the inference infrastructure layer for TuneLab 2.0, Eli Lilly's collaborative AI/ML drug discovery platform.
View Cached Full Text
Cached at: 06/11/26, 09:42 PM
We’re proud to share that @TamarindBio has been selected to build, host, and operate the inference infrastructure layer for TuneLab2.0, the next evolution of the platform. @EliLillyandCo TuneLab is a first-of-its-kind, collaborative AI/ML drug discovery platform, bringing models trained on over $1B worth of Lilly proprietary data to the biotech ecosystem.
Tamarind will power TuneLab’s scalable drug discovery workflows and model inference.
Similar Articles
@tenstorrent: Thank you Tokyo! Here’s everything we announced at TT-Deploy Japan: Faster AI Inference • Kimi K2.6 900 t/s/u, 3x faste…
Tenstorrent announced at TT-Deploy Japan faster AI inference for Kimi K2.6, LTX 2.3, and DeepSeek-R1 on their hardware, plus the licensable TT-Ascalon S RISC-V CPU for agentic AI.
@tuhinone: https://x.com/tuhinone/status/2069089174494625907
Baseten announces a $1.5B Series F funding round led by multiple investors, citing 20x revenue growth and 40x inference volume growth as evidence of the market's shift toward inference as the key AI layer.
@danshipper: we @every make investments every so often in founders building things in AI who we think are excellent @ninklefitz is o…
Nicole Fitzgerald announces Tacit Labs, a new applied research lab at the intersection of AI and biology, with investment from Every.
@charles_irl: bits to bio
Modal announces integration with Claude Science, providing elastic compute for life sciences researchers with up to $100K in committed resources.
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
Bristol Myers Squibb is deploying its second NVIDIA DGX SuperPOD based on DGX Vera Rubin NVL72 systems, creating the most powerful AI cluster in life sciences to accelerate drug discovery and make AI accessible to all scientists.